Dwek Raymond's Form 4 filing
United Therapeutics Corp (UTHR) · filed Aug 5, 2024
- Accession no.
- 0001415889-24-020750
- Filed
- Aug 5, 2024
- Trade date
- Aug 2, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 7 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.63M. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dwek RaymondCIK 0001231617 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2024 | Common Stock | MOption exerciseAcquired | +5,000 | $175.43 | +$877,150 | 6,750 | Direct | |
| Aug 2, 2024 | Common Stock | SSaleDisposed | −900 | $320.39F1 | −$288,351 | 5,850 | Direct | |
| Aug 2, 2024 | Common Stock | SSaleDisposed | −900 | $321.29F2 | −$289,161 | 4,950 | Direct | |
| Aug 2, 2024 | Common Stock | SSaleDisposed | −900 | $326.40F3 | −$293,760 | 4,050 | Direct | |
| Aug 2, 2024 | Common Stock | SSaleDisposed | −1,300 | $327.96F4 | −$426,348 | 2,750 | Direct | |
| Aug 2, 2024 | Common Stock | SSaleDisposed | −900 | $328.99F5 | −$296,091 | 1,850 | Direct | |
| Aug 2, 2024 | Common Stock | SSaleDisposed | −100 | $330.39 | −$33,039 | 1,750 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2024 | Common Stock | MOption exerciseDisposed | −5,000 | $0.00 | $0 | 10,000 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $320.04 to $320.8924. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F2
This transaction was executed in multiple trades at prices ranging from $321.14 to $321.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $325.98 to $326.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $327.505 to $328.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $328.54 to $329.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.